Clinical trial: A Phase Ib Study of Nivolumab in Patients With Autoimmune Disorders and Advanced Malignancies (AIM-NIVO)
Clinical trial: A Phase Ib Study of Nivolumab in Patients With Autoimmune Disorders and Advanced Malignancies (AIM-NIVO)
Clinical trial: A Phase 1/2a, Open-Label, Dose-Escalation Study to Evaluate the Safety and Preliminary Efficacy of TRX319 in Subjects With Primary or Secondary Progressive Multiple Sclerosis
Clinical trial: Factorial Optimization Randomized Controlled Trial to Test The Effects of Cognitive Behavioral Therapy Components For Multiple Sclerosis Fatigue
Clinical trial: The Effect of Qigong on Functional Outcomes, Balance, General Well-Being, and Depression in Patients Diagnosed With Multiple Sclerosis
Clinical trial: Consolidation Therapy With Immune Reconstitution Therapy (Cladribine) in Relapsing Multiple Sclerosis Patients Following a Treatment With Anti-CD20 Compounds: a Pivotal Study
Clinical trial: The Effects of Tai Chi and Square Stepping Exercises on Joint Position Sense and Clinical Outcomes in Women With Multiple Sclerosis
Clinical trial: Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy: A Pilot Study
Clinical trial: SurfSubQ - A Prospective Longitudinal Multicenter Observational Study to Investigate Neurofilament Light Chain Levels and Patient Satisfaction After Subcutaneous Ocrelizumab Administration in Persons With Multiple Sclerosis
Retsat variant (Q247R) found in high-altitude-adapted species revealed a central pathway governing CNS myelination and repair. Retsat and dihydroretinoids are pivotal regulators of white matter integrity. Administration of ATDR, a prodrug, promotes remyelination in multiple myelin injury models.
Clinical trial: The Effect of Qigong on Functional Outcomes, Balance, General Well-Being, and Depression in Patients Diagnosed With Multiple Sclerosis